Comprehensive Surgical Staging for Endometrial Cancer in Obese Patients: Comparing Robotics and Laparotomy

OBJECTIVE: To compare adequacy and outcomes of surgical staging for endometrial cancer in obese women by robotics or laparotomy. METHODS: Clinical stage I or occult stage II endometrial cancer patients with body mass indexes (BMIs) of at least 30 (BMI is calculated as weight (kg)/[height (m)]2) were identified undergoing robotic staging and matched 1:2 with laparotomy patients. Patient characteristics, operative times, complications, and pathologic factors were collected. An adequate lymphadenectomy was defined arbitrarily as at least 10 total nodes removed, and adequate pelvic and paraaortic lymphadenectomy was defined as at least six and at least four nodes removed, respectively. RESULTS: A total of 109 patients underwent surgery with the intent of robotic staging and were matched to 191 laparotomy patients. The mean BMI was 40 for each group. The robotic conversion rate was 15.6% (95% confidence interval [CI] 9.5–24.2%). Ninety-two completed robotic patients were compared with 162 matched laparotomy patients. The two groups were comparable regarding total lymph node count (25±13 compared with 24±12, P=.45) and the percentage of patients undergoing adequate lymphadenectomy (85% compared with 91%, P=.16) and adequate pelvic (90% compared with 95%, P=.16) and aortic lymphadenectomy (76% compared with 79%, P=.70) for robotic and laparotomy patients, respectively, but there was limited power to detect this difference. The blood transfusion rate (2% compared with 9%, odds ratio [OR] 0.22, 95% CI 0.05–0.97, P=.046), the number of nights in the hospital (1 compared with 3, P<.001), complications (11% compared with 27%, OR 0.29, 95% CI 0.13–0.65 P=.003), and wound problems (2% compared with 17%, OR 0.10, 95% CI 0.02–0.43, P=.002) were reduced for robotic surgery. CONCLUSION: In obese women with endometrial cancer, robotic comprehensive surgical staging is feasible. Importantly, obesity may not compromise the ability to adequately stage patients robotically. LEVEL OF EVIDENCE: II

[1]  G. Phillips,et al.  Minimally invasive comprehensive surgical staging for endometrial cancer: Robotics or laparoscopy? , 2009, Gynecologic oncology.

[2]  N. Spirtos,et al.  Gynecologic Oncology Group Surgical Procedures Manual , 2009 .

[3]  G. Phillips,et al.  Robotic Hysterectomy and Pelvic–Aortic Lymphadenectomy for Endometrial Cancer , 2008, Obstetrics and gynecology.

[4]  P. Gehrig,et al.  What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman? , 2008, Gynecologic oncology.

[5]  Susan F. Davis.  State-specific prevalence of obesity among adults--United States, 2007. , 2008, MMWR. Morbidity and mortality weekly report.

[6]  R. Barakat,et al.  Comparing Surgical Outcomes in Obese Women Undergoing Laparotomy, Laparoscopy, or Laparotomy With Panniculectomy for the Staging of Uterine Malignancy , 2007, Annals of Surgical Oncology.

[7]  R. Barakat,et al.  Twelve-year experience in the management of endometrial cancer: a change in surgical and postoperative radiation approaches. , 2007, Gynecologic oncology.

[8]  R. Coleman,et al.  The use of adjuvant radiation therapy in early endometrial cancer by members of the Society of Gynecologic Oncologists in 2005. , 2007, Gynecologic oncology.

[9]  R. Reynolds,et al.  Laparoscopic technology for the treatment of endometrial cancer , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[10]  N. Abu-Rustum.  CO(2) pneumoperitoneum or the Bookwalter: choose your access and exposure. , 2005, Gynecologic oncology.

[11]  R. Tozzi,et al.  Analysis of morbidity in patients with endometrial cancer: is there a commitment to offer laparoscopy? , 2005, Gynecologic oncology.

[12]  N. Ramirez,et al.  Morbid obesity and endometrial cancer: surgical, clinical, and pathologic outcomes in surgically managed patients. , 2004, Gynecologic oncology.

[13]  R. Kaaks,et al.  Obesity , Endogenous Hormones , and Endometrial Cancer Risk : A Synthetic Review 1 , 2002 .

[14]  R. Mannel,et al.  Laparoscopic pelvic and paraaortic lymph node dissection in the obese. , 2002, Gynecologic oncology.

[15]  S. Soong,et al.  Conservative management of stage I endometrial carcinoma after surgical staging. , 2002, Gynecologic oncology.

[16]  H. Adami,et al.  Overweight as an avoidable cause of cancer in Europe , 2001, International journal of cancer.

[17]  Treatment of Obesity in Adults.  Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. , 1998, Obesity research.

[18]  G. Gross,et al.  Cost and quality-of-life analyses of surgery for early endometrial cancer: laparotomy versus laparoscopy. , 1996, American journal of obstetrics and gynecology.

[19]  N. Kadar.  Laparoscopic pelvic lymphadenectomy in obese women with gynecologic malignancies. , 1995, The Journal of the American Association of Gynecologic Laparoscopists.